S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,023.00 +0.94% CRUDE 81.77 +3.57%
Next Bullish Trade
Sign in
IOVA

Iovance Biotherapeutics, Inc. IOVA

$5.00 +0.34 (+7.30%)
Extended · +1.79σ
Mkt cap $2.1B
P/E
Day $4.44 – $5.07
52wk $2.24 – $5.63
Avg vol
Beta
Div yld
Next earnings

Quick read

Plain English

Iovance Biotherapeutics, Inc. is a healthcare company listed in the US.

IOVA last traded at $5, up 7.3% on the day; that's in the upper part of its 52-week range ($2.24–$5.63). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →
21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 65), the trend is quiet (ADX 20), and volume is about normal (1.3×). On the business side, revenue is growing 45% year over year and the business keeps about -57 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI
65
0–100 · <30 oversold
Trend strength · ADX
20
>25 = strong trend
Volume vs avg
1.35×
1× = average
Stretch from avg
+1.9 ATR
− below · + above
Zone touches
0
tests of this zone
Suggested hold
3–30
bars (≈ days)
Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth
+44.8%
year over year
Free-cash-flow margin
-56.6%
cash kept per $ of sales
Debt / equity
0.07
lower = less leveraged

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Fair-value range
$1.77 – $1.77
Verdict
Unknown
Accounting quality Weak
  • ✓ More cash than debt
  • ✓ Quick ratio 2.86 (antifragile)
  • ✓ Current ratio 3.20 (antifragile)
  • ✓ Debt/equity 0.31 (antifragile)
  • ⚠ Negative retained earnings
  • ⚠ Stock comp 23% of revenue (heavy dilution)

Key statistics

All statistics →

IOVA is a $2.1 billion company.

Mkt cap $2.1B
P/E ttm
Fwd P/E
Beta
Day range $4.44 – $5.07
52w range $2.24 – $5.63
Avg vol
RSI(2) 88.5
ROE
Net mgn
FCF mgn -56.6%
Debt/Eq 0.07
Div yld
Sector Healthcare
Industry Biotechnology
Next earn
52-week range · today's price
$2.24$5.63

More on IOVA